Connection

DAVID ALLISON to Simian Immunodeficiency Virus

This is a "connection" page, showing publications DAVID ALLISON has written about Simian Immunodeficiency Virus.
Connection Strength

0.901
  1. The Frequency of Vaccine-Induced T-Cell Responses Does Not Predict the Rate of Acquisition after Repeated Intrarectal SIVmac239 Challenges in Mamu-B*08+ Rhesus Macaques. J Virol. 2019 03 01; 93(5).
    View in: PubMed
    Score: 0.142
  2. Mamu-B*17+ Rhesus Macaques Vaccinated with env, vif, and nef Manifest Early Control of SIVmac239 Replication. J Virol. 2018 08 15; 92(16).
    View in: PubMed
    Score: 0.137
  3. Vaccine-induced immune responses against both Gag and Env improve control of simian immunodeficiency virus replication in rectally challenged rhesus macaques. PLoS Pathog. 2017 Jul; 13(7):e1006529.
    View in: PubMed
    Score: 0.127
  4. Vaccine-Induced Simian Immunodeficiency Virus-Specific CD8+ T-Cell Responses Focused on a Single Nef Epitope Select for Escape Variants Shortly after Infection. J Virol. 2015 Nov; 89(21):10802-20.
    View in: PubMed
    Score: 0.112
  5. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med. 2008 Oct 27; 205(11):2537-50.
    View in: PubMed
    Score: 0.069
  6. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol. 2006 Jun; 80(12):5875-85.
    View in: PubMed
    Score: 0.059
  7. Expression of the major histocompatibility complex class I molecule Mamu-A*01 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol. 2003 Feb; 77(4):2736-40.
    View in: PubMed
    Score: 0.047
  8. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. J Virol. 2002 Oct; 76(20):10507-11.
    View in: PubMed
    Score: 0.046
  9. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. J Virol. 2002 Apr; 76(8):4108-12.
    View in: PubMed
    Score: 0.044
  10. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature. 2000 Sep 21; 407(6802):386-90.
    View in: PubMed
    Score: 0.040
  11. Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques. PLoS Pathog. 2019 09; 15(9):e1008015.
    View in: PubMed
    Score: 0.037
  12. Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239. J Virol. 2014 Jul; 88(13):7493-516.
    View in: PubMed
    Score: 0.025
  13. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J Immunol. 2007 Mar 01; 178(5):2746-54.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.